Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Managing Severe Evaporative Dry Eye with Intense Pulsed Light Therapy.
Qin G, Chen J, Li L, Xia Y, Zhang Q, Wu Y, Yang L, Moutari S, Moore JE, Xu L, He W, Yu S, He X, Pazo EE. Qin G, et al. Among authors: moore je. Ophthalmol Ther. 2023 Apr;12(2):1059-1071. doi: 10.1007/s40123-023-00649-5. Epub 2023 Jan 24. Ophthalmol Ther. 2023. PMID: 36693992 Free PMC article.
The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study.
Chen J, Qin G, Li L, Qi Y, Xia Y, Zhang Q, Wu Y, You Y, Yang L, Guo N, Moutari S, Moore JE, Bu S, Xu L, He W, Yu S, Pazo EE, He X. Chen J, et al. Among authors: moore je. Ophthalmol Ther. 2023 Dec;12(6):2959-2971. doi: 10.1007/s40123-023-00784-z. Epub 2023 Aug 17. Ophthalmol Ther. 2023. PMID: 37589932 Free PMC article.
Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome.
Chen J, Qin G, Li L, Qi Y, Che H, Huang H, Xia Y, Zhang Q, Wu Y, Yang L, Moutari S, Moore JE, Xu L, He W, Yu S, Pazo EE, He X. Chen J, et al. Among authors: moore je. BMJ Open. 2023 Aug 29;13(8):e073055. doi: 10.1136/bmjopen-2023-073055. BMJ Open. 2023. PMID: 37643847 Free PMC article.
Correction: The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study.
Chen J, Qin G, Li L, Qi Y, Xia Y, Zhang Q, Wu Y, You Y, Yang L, Guo N, Moutari S, Moore JE, Bu S, Xu L, He W, Yu S, Pazo EE, He X. Chen J, et al. Among authors: moore je. Ophthalmol Ther. 2023 Dec;12(6):2973-2975. doi: 10.1007/s40123-023-00806-w. Ophthalmol Ther. 2023. PMID: 37713066 Free PMC article. No abstract available.
A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease.
Chen J, Chen Y, Qin G, Li L, Li M, Cheng Y, Zhuang S, Li Z, Zhang Q, Wu Y, Yang L, Moutari S, Moore JE, Xu L, He W, Yu S, Pazo EE, He X. Chen J, et al. Among authors: moore je. Trials. 2023 Dec 12;24(1):803. doi: 10.1186/s13063-023-07818-8. Trials. 2023. PMID: 38087329 Free PMC article.
Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye.
Qin G, Chen J, Li L, Qi Y, Chen Y, Zhang Q, Wu Y, You Y, Yang L, Guo N, Moutari S, Bu S, Moore JE, Xu L, He W, Yu S, He X, Pazo EE. Qin G, et al. Among authors: moore je. J Ocul Pharmacol Ther. 2023 Dec 13. doi: 10.1089/jop.2023.0098. Online ahead of print. J Ocul Pharmacol Ther. 2023. PMID: 38100078
1,168 results